Bayer AG forecasts consumer health product sales growth in 2025 as high as 5% on adjusted measure including impact from currency exchange and portfolio changes after the sector’s results for 2024 were down 3% on a reported basis, or up 2% adjusted.
A key driver for growth in consumer health and across Bayer’s sectors, says CEO Bill Anderson, is the “dynamic shared ownership program” the firm introduced...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?